Neutrophil extracellular traps promote differentiation and function of fibroblasts

Journal of Pathology

Volumn 233, Issue 3, 2014, Pages 294-307

  Chrysanthopoulou, Akrivi ^a   Mitroulis, Ioannis ^b   Apostolidou, Eirini ^a   Arelaki, Stella ^c   Mikroulis, Dimitrios ^c   Konstantinidis, Theocharis ^a   Sivridis, Efthimios ^c   Koffa, Maria ^a   Giatromanolaki, Alexandra ^c   Boumpas, Dimitrios T ^d,e   Ritis, Konstantinos ^a,c   Kambas, Konstantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

autophagy; fibroblast; fibrosis; IL 17; neutrophil extracellular traps

Indexed keywords

AUTOPHAGY; FIBROBLAST; FIBROSIS; IL-17; NEUTROPHIL EXTRACELLULAR TRAPS;

ACTINS; AUTOPHAGY; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN; CICATRIX; COCULTURE TECHNIQUES; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME INHIBITORS; FIBROSIS; HUMANS; INTERLEUKIN-17; LUNG; MYOFIBROBLASTS; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; PARACRINE COMMUNICATION; PEROXIDASE; PHENOTYPE; PULMONARY FIBROSIS; SKIN;

EID: 84902371792     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4359     Document Type: Article

References (68)

1. Brass DM, Spencer JC, Li Z, et al., Innate immune activation by inhaled lipopolysaccharide, independent of oxidative stress, exacerbates silica-induced pulmonary fibrosis in mice. PLoS One 2012; 7: e40789.
2. Donaldson K, Poland CA, Murphy FA, et al., Pulmonary toxicity of carbon nanotubes and asbestos-similarities and differences. Adv Drug Deliv Rev 2013; 65: 2078-2086.
3. Chen J, Stubbe J,. Bleomycins: towards better therapeutics. Nature Rev Cancer 2005; 5: 102-112.
4. Denham JW, Hauer-Jensen M,. The radiotherapeutic injury-a complex 'wound'. Radiother Oncol 2002; 63: 129-145.
5. Noble PW, Barkauskas CE, Jiang D,. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 2012; 122: 2756-2762.
6. Maestrelli P, Saetta M, Mapp CE, et al., Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S76-S80.
7. Selman M, King TE, Pardo A,. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-151.
8. [No authors listed] Cigarette smoking and health. American Thoracic Society. Am J Respir Crit Care Med 1996; 153: 861-865.
9. Scanlon PD, Connett JE, Waller LA, et al., Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
10. Roche N, Marthan R, Berger P, et al., Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev 2011; 20: 175-182.
11. Kennedy L, Sahn SA,. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215-1222.
12. Baylor PA, Sobenes JR, Vallyathan V,. Interstitial pulmonary fibrosis and progressive massive fibrosis related to smoking methamphetamine with talc as filler. Respir Care 2013; 58: e53-e55.
13. Peng R, Sridhar S, Tyagi G, et al., Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model-for 'active' disease. PLoS One 2013; 8: e59348.
14. John G, Kohse K, Orasche J, et al., The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin Sci (Lond) 2014; 126: 207-221.
15. Tamimi A, Serdarevic D, Hanania NA,. The effect of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med 2012; 106: 319-328.
16. Stockley RA,. Neutrophils and the pathogenesis of COPD. Chest 2002; 121 (Suppl): 151-155.
17. Montes JF, Ferrer J, Villarino MA, et al., Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med 2003; 168: 348-355.
18. Craig VJ, Quintero PA, Fyfe SE, et al., Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol 2013; 190: 4283-4296.
19. Remijsen Q, Vanden Berghe T, Wirawan E, et al., Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 2011; 21: 290-304.
20. Li P, Li M, Lindberg MR, et al., PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010; 207: 1853-1862.
21. Neeli I, Radic M,. Knotting the NETs: analyzing histone modifications in neutrophil extracellular traps. Arthritis Res Ther 2012; 14: 115.
22. Remijsen Q, Kuijpers TW, Wirawan E, et al., Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ 2011; 18: 581-588.
23. Cheng OZ, Palaniyar N,. NET balancing: a problem in inflammatory lung diseases. Front Immunol 2013; 4: 1.
24. Manzenreiter R, Kienberger F, Marcos V, et al., Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros 2011; 11: 84-92.
25. Caudrillier A, Kessenbrock K, Gilliss BM, et al., Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-2671.
26. Dworski R, Simon HU, Hoskins A, et al., Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 2011; 127: 1260-1266.
27. Narasaraju T, Yang E, Samy RP, et al., Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011; 179: 199-210.
28. Tan Z, Qian X, Jiang R, et al., IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191: 1835-1844.
29. Wilson MS, Madala SK, Ramalingam TR, et al., Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010; 207: 535-552.
30. Gasse P, Riteau N, Vacher R, et al., IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One 2011; 6: e23185.
31. Lin AM, Rubin CJ, Khandpur R, et al., Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187: 490-500.
32. Villanueva E, Yalavarthi S, Berthier CC, et al., Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538-552.
33. Ward PA, Hunninghake GW,. Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998; 157: 123-129.
34. Mori R, Shaw TJ, Martin P,. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205: 43-51.
35. Mitroulis I, Kambas K, Chrysanthopoulou A, et al., Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. PLoS One 2011; 6: e29318.
36. Chrysanthopoulou A, Mitroulis I, Kambas K, et al., Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A. Arthritis Rheum 2011; 63: 3586-3597.
37. Kramann R, Dirocco DP, Humphreys BD,. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. J Pathol 2013; 231: 273-289.
38. Vassallo R, Tamada K, Lau JS, et al., Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005; 175: 2684-2691.
39. Kambas K, Mitroulis I, Apostolidou E, et al., Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 2012; 7: e45427.
40. Saffarzadeh M, Juenemann C, Queisser MA, et al., Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012; 7: e32366.
41. Kerna I, Kisand K, Suutre S, et al., The ADAM12 is upregulated in synovitis and postinflammatory fibrosis of the synovial membrane in patients with early radiographic osteoarthritis. Joint Bone Spine 2014; 81: 51-56.
42. Taniguchi T, Asano Y, Akamata K, et al., Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis. J Eur Acad Dermatol Venereol 2013; 27: 747-753.
43. Shi-Wen X, Leask A, Abraham D,. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008; 19: 133-144.
44. Grommes J, Soehnlein O,. Contribution of neutrophils to acute lung injury. Mol Med 2011; 17: 293-307.
45. Watt AP, Schock BC, Ennis M,. Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr Drug Targets Inflamm Allergy 2005; 4: 415-423.
46. Kambas K, Chrysanthopoulou A, Vassilopoulos D, et al., Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis 2013; DOI:10.1136/annrheumdis-2013-203430.
47. Spallotta F, Tardivo S, Nanni S, et al., Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia. J Biol Chem 2013; 288: 29915-29929.
48. Fuchs TA, Brill A, Duerschmied D, et al., Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107: 15880-15885.
49. Garcia-Romo GS, Caielli S, Vega B, et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra20.
50. Zeisberg M, Hanai J, Sugimoto H, et al., BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Med 2003; 9: 964-968.
51. Seki E, De Minicis S, Osterreicher CH, et al., TLR4 enhances TGF-beta signalling and hepatic fibrosis. Nature Med 2007; 13: 1324-1332.
52. Green FH, Vallyathan V, Hahn FF,. Comparative pathology of environmental lung disease: an overview. Toxicol Pathol 2007; 35: 136-147.
53. Mouratis MA, Aidinis V,. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 2011; 17: 355-361.
54. Nakamura Y, Romberger DJ, Tate L, et al., Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med 1995; 151: 1497-1503.
55. Carnevali S, Nakamura Y, Mio T, et al., Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol 1998; 274: L591-L598.
56. Ishii T, Fujishiro M, Masuda M, et al., Depletion of glutathione S-transferase P1 induces apoptosis in human lung fibroblasts. Exp Lung Res 2003; 29: 523-536.
57. Carnevali S, Petruzzelli S, Longoni B, et al., Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003; 284: L955-L963.
58. Jeffery PK,. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53: 129-136.
59. van den Heuvel MM, Smit HJ, Barbierato SB, et al., Talc-induced inflammation in the pleural cavity. Eur Respir J 1998; 12: 1419-1423.
60. Psathakis K, Calderõn-Osuna E, Romero-Romero B, et al., The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J 2006; 27: 817-821.
61. Saito F, Tasaka S, Inoue K, et al., Role of interleukin-6 in bleomycin induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 2008; 38: 566-571.
62. Pinho V, Russo RC, Amaral FA, et al., Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. J Immunol 2007; 179: 7891-7898.
63. Thomas GM, Carbo C, Curtis BR, et al., Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012; 119: 6335-6343.
64. Papayannopoulos V, Staab D, Zychlinsky A,. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PLoS One 2011; 6: e28526.
65. Ratjen F, Paul K, van Koningsbruggen S, et al., DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha. Pediatr Pulmonol 2005; 39: 1-4.
66. Paul K, Rietschel E, Ballmann M, et al., Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 719-725.
67. Van Der Vliet A, Nguyen MN, Shigenaga MK, et al., Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2000; 279: L537-L546.
68. Kambas K, Chrysanthopoulou A, Kourtzelis I, et al., Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade. J Immunol 2011; 186: 6568-6575.